Business Context and Reporting Period
Company: Spectral AI, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 22, 2025 (Event Date); October 24, 2025 (Closing Date)
Reporting Period: Specific transaction event regarding a registered direct offering and concurrent private placement.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than periodic financial performance. Key transaction metrics include:
- Aggregate Gross Proceeds: Approximately $7,600,000 (before fees and expenses).
- Common Stock Sold: 3,065,000 shares at $1.90 per share.
- Warrants Issued: 4,000,000 warrants with an exercise price of $2.51 per share.
- Pre-Funded Warrants Issued: 935,000 pre-funded warrants with a purchase price of $1.8999 and an exercise price of $0.0001.
- Placement Agent Fee: 6.00% of aggregate gross proceeds from the sale of Shares.
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity metrics. These figures are not applicable to this specific transaction report.
Material Changes and Agreements
The Company entered into the following material definitive agreements on October 22, 2025:
- Securities Purchase Agreement: Sale of common stock, warrants, and pre-funded warrants to a specific investor.
- Placement Agency Agreement: Northland Securities, Inc. appointed as sole placement agent on a reasonable best efforts basis.
- Registration Rights Agreement: Investor granted rights to require the Company to file a registration statement (Form S-3) for the resale of securities within 10 days of the agreement.
Outlook, Risks, and Management Commentary
Management Commentary: The Company intends to use net proceeds for working capital and general corporate purposes. The Board of Directors will recommend stockholder approval for the issuance of shares underlying the Warrants.
Key Conditions and Risks:
- Stockholder Approval: Warrants are exercisable upon the earlier of stockholder approval or six months post-issuance. If approval is not obtained by June 1, 2026, the Company must call meetings every 90 days until approval is secured.
- Ownership Caps: Holders cannot exercise warrants if it would result in beneficial ownership exceeding 4.99% (Warrants) or 9.99% (Pre-Funded Warrants), unless they elect to increase the cap (effective after 61 days).
- Fundamental Transactions: In the event of a merger or acquisition, warrant holders may have the right to require redemption of unexercised warrants at their Black Scholes Value.
- Forward-Looking Statements: The filing contains forward-looking statements subject to risks and uncertainties, including the completion of the offering and satisfaction of closing conditions.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 6.00% placement fee and other transaction expenses.
- Confirm the timeline for the upcoming stockholder meeting required to approve the Warrant shares.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and representations.
- Monitor the effectiveness of the Form S-3 registration statement required under the Registration Rights Agreement.
- Assess the dilution impact of the 3,065,000 shares, 4,000,000 warrants, and 935,000 pre-funded warrants on existing shareholders.